SLC22A5 and cancer: At the same time, luteolin also promoted the expression of PDZ domain-containing 1 (PDZK1) and PDZ domain-containing 3 (PDZK2), which increased OCTN2 expression on cancer cell surfaces with enhanced transporter activity [219].